708 related articles for article (PubMed ID: 29751586)
1. Telomere Maintenance Mechanisms in Cancer.
Gaspar TB; Sá A; Lopes JM; Sobrinho-Simões M; Soares P; Vinagre J
Genes (Basel); 2018 May; 9(5):. PubMed ID: 29751586
[TBL] [Abstract][Full Text] [Related]
2. Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT).
De Vitis M; Berardinelli F; Sgura A
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463031
[TBL] [Abstract][Full Text] [Related]
3. Alternative lengthening of telomeres is the major telomere maintenance mechanism in astrocytoma with isocitrate dehydrogenase 1 mutation.
Ferreira MSV; Sørensen MD; Pusch S; Beier D; Bouillon AS; Kristensen BW; Brümmendorf TH; Beier CP; Beier F
J Neurooncol; 2020 Mar; 147(1):1-14. PubMed ID: 31960234
[TBL] [Abstract][Full Text] [Related]
4. The telomere maintenance mechanism spectrum and its dynamics in gliomas.
Kim S; Chowdhury T; Yu HJ; Kahng JY; Lee CE; Choi SA; Kim KM; Kang H; Lee JH; Lee ST; Won JK; Kim KH; Kim MS; Lee JY; Kim JW; Kim YH; Kim TM; Choi SH; Phi JH; Shin YK; Ku JL; Lee S; Yun H; Lee H; Kim D; Kim K; Hur JK; Park SH; Kim SK; Park CK
Genome Med; 2022 Aug; 14(1):88. PubMed ID: 35953846
[TBL] [Abstract][Full Text] [Related]
5. Reliable assessment of telomere maintenance mechanisms in neuroblastoma.
Meeser A; Bartenhagen C; Werr L; Hellmann AM; Kahlert Y; Hemstedt N; Nürnberg P; Altmüller J; Ackermann S; Hero B; Simon T; Peifer M; Fischer M; Rosswog C
Cell Biosci; 2022 Sep; 12(1):160. PubMed ID: 36153564
[TBL] [Abstract][Full Text] [Related]
6. Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma.
Koneru B; Lopez G; Farooqi A; Conkrite KL; Nguyen TH; Macha SJ; Modi A; Rokita JL; Urias E; Hindle A; Davidson H; Mccoy K; Nance J; Yazdani V; Irwin MS; Yang S; Wheeler DA; Maris JM; Diskin SJ; Reynolds CP
Cancer Res; 2020 Jun; 80(12):2663-2675. PubMed ID: 32291317
[TBL] [Abstract][Full Text] [Related]
7. Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood.
Minasi S; Baldi C; Pietsch T; Donofrio V; Pollo B; Antonelli M; Massimino M; Giangaspero F; Buttarelli FR
J Neurooncol; 2019 May; 142(3):435-444. PubMed ID: 30830680
[TBL] [Abstract][Full Text] [Related]
8. Pan-Cancer Analysis of Clinical Relevance via Telomere Maintenance Mechanism.
Sung JY; Cheong JH
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681758
[TBL] [Abstract][Full Text] [Related]
9. Pan-cancer analysis of telomere maintenance mechanisms.
Hakobyan M; Binder H; Arakelyan A
J Biol Chem; 2024 May; 300(6):107392. PubMed ID: 38763334
[TBL] [Abstract][Full Text] [Related]
10. Human sarcomas are mosaic for telomerase-dependent and telomerase-independent telomere maintenance mechanisms: implications for telomere-based therapies.
Gocha AR; Nuovo G; Iwenofu OH; Groden J
Am J Pathol; 2013 Jan; 182(1):41-8. PubMed ID: 23260199
[TBL] [Abstract][Full Text] [Related]
11. The CDKN2A G500 allele is more frequent in GBM patients with no defined telomere maintenance mechanism tumors and is associated with poorer survival.
Royds JA; Al Nadaf S; Wiles AK; Chen YJ; Ahn A; Shaw A; Bowie S; Lam F; Baguley BC; Braithwaite AW; MacFarlane MR; Hung NA; Slatter TL
PLoS One; 2011; 6(10):e26737. PubMed ID: 22046342
[TBL] [Abstract][Full Text] [Related]
12. Telomere maintenance mechanisms in cancer: telomerase, ALT or lack thereof.
Claude E; Decottignies A
Curr Opin Genet Dev; 2020 Feb; 60():1-8. PubMed ID: 32114293
[TBL] [Abstract][Full Text] [Related]
13. TERT-Regulation and Roles in Cancer Formation.
Dratwa M; Wysoczańska B; Łacina P; Kubik T; Bogunia-Kubik K
Front Immunol; 2020; 11():589929. PubMed ID: 33329574
[TBL] [Abstract][Full Text] [Related]
14. Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma.
George SL; Parmar V; Lorenzi F; Marshall LV; Jamin Y; Poon E; Angelini P; Chesler L
J Exp Clin Cancer Res; 2020 May; 39(1):78. PubMed ID: 32375866
[TBL] [Abstract][Full Text] [Related]
15. Alternative lengthening of telomeres in molecular subgroups of paediatric high-grade glioma.
Minasi S; Baldi C; Gianno F; Antonelli M; Buccoliero AM; Pietsch T; Massimino M; Buttarelli FR
Childs Nerv Syst; 2021 Mar; 37(3):809-818. PubMed ID: 33128602
[TBL] [Abstract][Full Text] [Related]
16. TERT promoter mutations in telomere biology.
Heidenreich B; Kumar R
Mutat Res Rev Mutat Res; 2017; 771():15-31. PubMed ID: 28342451
[TBL] [Abstract][Full Text] [Related]
17. Telomerase reverse transcriptase expression protects transformed human cells against DNA-damaging agents, and increases tolerance to chromosomal instability.
Fleisig HB; Hukezalie KR; Thompson CA; Au-Yeung TT; Ludlow AT; Zhao CR; Wong JM
Oncogene; 2016 Jan; 35(2):218-27. PubMed ID: 25893297
[TBL] [Abstract][Full Text] [Related]
18. How Do Telomere Abnormalities Regulate the Biology of Neuroblastoma?
Akter J; Kamijo T
Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439779
[TBL] [Abstract][Full Text] [Related]
19. Evidence for alternative lengthening of telomeres in liposarcomas in the absence of ALT-associated PML bodies.
Jeyapalan JN; Mendez-Bermudez A; Zaffaroni N; Dubrova YE; Royle NJ
Int J Cancer; 2008 Jun; 122(11):2414-21. PubMed ID: 18311780
[TBL] [Abstract][Full Text] [Related]
20. Internal genomic regions mobilized for telomere maintenance in C. elegans.
Kim C; Sung S; Lee J
Worm; 2016; 5(1):e1146856. PubMed ID: 27073737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
